Roger J. Daly mainly focuses on Cell biology, SH3 domain, SH2 domain, Receptor tyrosine kinase and GRB2. As part of his studies on Cell biology, he often connects relevant areas like Receptor. His SH3 domain study contributes to a more complete understanding of Biochemistry.
His SH2 domain research incorporates themes from Molecular biology, Insulin receptor substrate and Insulin Receptor Substrate Proteins. The various areas that he examines in his Receptor tyrosine kinase study include Cancer research and Epidermal growth factor receptor. Roger J. Daly works in the field of GRB2, focusing on GRB2 Adaptor Protein in particular.
Roger J. Daly mainly investigates Cancer research, Cell biology, Signal transduction, Phosphorylation and Tyrosine phosphorylation. Roger J. Daly has included themes like Carcinogenesis, Cancer, Cell growth, Tyrosine kinase and Receptor tyrosine kinase in his Cancer research study. His work deals with themes such as Cortactin and Bioinformatics, which intersect with Cell biology.
His Signal transduction study integrates concerns from other disciplines, such as Receptor, Epidermal growth factor receptor and Endocrinology. His Phosphorylation study incorporates themes from Molecular biology and Kinase. His GRB2 research focuses on SH2 domain and how it relates to SH3 domain.
Roger J. Daly focuses on Cancer research, Cell biology, Phosphorylation, Prostate cancer and Cell growth. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Tumor microenvironment, Chemokine and Innate immune system. His Cell biology research is multidisciplinary, incorporating elements of HEK 293 cells, Cell and Epidermal growth factor.
His Phosphorylation research includes themes of Tyrosine kinase and Kinase. His biological study spans a wide range of topics, including Programmed cell death, Receptor, Glucocorticoid receptor and PI3K/AKT/mTOR pathway, PTEN. His study explores the link between Tyrosine phosphorylation and topics such as Cell migration that cross with problems in Src family kinase, Motility, GRB2, Signalling and Function.
Roger J. Daly mostly deals with Cancer research, Prostate cancer, Tumor microenvironment, Docetaxel and Proteome. His Cancer research research integrates issues from Inflammation, Chemokine, Interleukin 8, Wound healing and Innate immune system. His Prostate cancer research is multidisciplinary, incorporating perspectives in Regulation of gene expression, Prostate, microRNA and Epigenome.
Roger J. Daly has researched Tumor microenvironment in several fields, including Bisulfite sequencing, Differentially methylated regions, DNA methylation, Gene expression profiling and Epigenetics. His Docetaxel study combines topics from a wide range of disciplines, such as Taxane, Cabazitaxel, Apoptosis, Gene knockdown and Cancer cell. His Proteome research incorporates elements of Extracellular matrix, Signal transduction, Cell biology, Cell adhesion and Cancer-Associated Fibroblasts.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
E.J. Lowenstein;R.J. Daly;A.G. Batzer;W. Li.
Cell (1992)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras.
Nature (2012)
Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.
M. Rozakis-Adcock;J. McGlade;G. Mbamalu;G. Pelicci.
Nature (1992)
Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.
N. Li;A. Batzer;R. Daly;V. Yajnik.
Nature (1993)
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc : implications for insulin control of ras signalling
E Y Skolnik;C H Lee;A Batzer;L M Vicentini.
The EMBO Journal (1993)
Dual-specificity phosphatases: critical regulators with diverse cellular targets.
Kate I Patterson;Tilman Brummer;Phillipa M O'Brien;Roger John Daly.
Biochemical Journal (2009)
PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality
Elena Lopez-Knowles;Sandra A O'Toole;Catriona M McNeil;Catriona M McNeil;Ewan K. A Millar.
International Journal of Cancer (2010)
SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.
D. Rotin;B. Margolis;M. Mohammadi;R.J. Daly.
The EMBO Journal (1992)
iFeature: a Python package and web server for features extraction and selection from protein and peptide sequences.
Zhen Chen;Pei Zhao;Fuyi Li;André Leier.
Bioinformatics (2018)
Cortactin signalling and dynamic actin networks.
Roger J. Daly.
Biochemical Journal (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Glasgow
Garvan Institute of Medical Research
University of Glasgow
Garvan Institute of Medical Research
Monash University
University of Sydney
University of Queensland
University of Queensland
Garvan Institute of Medical Research
Monash University
IBM (United States)
Iowa State University
Universitat Politècnica de València
Sogang University
Ege University
University of Victoria
Commonwealth Scientific and Industrial Research Organisation
Kyungpook National University
Auburn University
Brigham and Women's Hospital
National Marine Fisheries Service
University of Nottingham
University of Chicago
Harvard University
Harvard University
University of Chicago